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Abstract
Recent studies using cell culture infection systems that recapitulate the entire life cycle of hepatitis C virus (HCV) indicate
that several nonstructural viral proteins, including NS2, NS3, and NS5A, are involved in the process of viral assembly and
release. Other recent work suggests that Ser-168 of NS2 is a target of CK2 kinase–mediated phosphorylation, and that this
controls the stability of the genotype 1a NS2 protein. Here, we show that Ser-168 is a critical determinant in the production
of infectious virus particles. Substitution of Ser-168 with Ala (or Gly) ablated production of infectious virus by cells
transfected with a chimeric viral RNA (HJ3-5) containing core-NS2 sequences from the genotype 1a H77 virus within the
background of genotype 2a JFH1 virus. An S168A substitution also impaired production of virus by cells transfected with
JFH1 RNA. This mutation did not alter polyprotein processing or genome replication. This defect in virus production could
be rescued by expression of wt NS2 in trans from an alphavirus replicon. The trans-complementing activities of NS2 from
genotypes 1a and 2a demonstrated strong preferences for rescue of the homologous genotype. Importantly, the S168A
mutation did not alter the association of core or NS5A proteins with host cell lipid droplets, nor prevent the assembly of
core into particles with sedimentation and buoyant density properties similar to infectious virus, indicating that NS2 acts
subsequent to the involvement of core, NS5A, and NS3 in particle assembly. Second-site mutations in NS2 as well as in NS5A
can rescue the defect in virus production imposed by the S168G mutation. In aggregate, these results indicate that NS2
functions in trans, in a late-post assembly maturation step, perhaps in concert with NS5A, to confer infectivity to the HCV
particle.
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Introduction
Persistent infection with hepatitis C virus (HCV) is a common
cause of chronic liver disease, and may lead to clinically severe
cirrhosis and/or hepatocellular carcinoma [1,2]. Over the two
decades that have elapsed since its discovery [3], much has been
learned about HCV, the proteins it encodes, and their roles in
genome replication. However, investigation of the complete viral
life cycle became possible only recently with the development of
tractable cell culture-based infection systems [4–7]. The availabil-
ity of these systems has accelerated studies of the mechanisms
underlying virus assembly and egress as well as cell entry. In
addition to the roles expected of the structural proteins (core, E1,
E2) in viral assembly, a number of recent studies suggest that
nonstructural proteins, such as NS3 and NS5A as well as p7 and
NS2, are also critically important in this process [6–16].
NS2 is a small membrane-bound protein with one or more
trans-membrane domains [17,18]. Up until recently, the only
known function of NS2 has been its role in polyprotein processing
as part of the auto-protease that cleaves in cis between NS2 and
NS3. However, data from several studies that have used cell
culture infection systems suggest the specific involvement of NS2
during the assembly of infectious HCV particles. We showed that
compensatory mutations accumulating within the N-terminal
domain of NS2 following transfection of an inter-genotypic, 1a/
2a chimeric viral RNA enhanced the specific infectivity of secreted
virus particles [14]. Subsequently, the deletion of NS2 sequence
was shown to block infectious virus production by an otherwise
viable di-cistronic HCV RNA that no longer required the NS2-
NS3 auto-protease for genome amplification [12]. A structure-
function analysis of NS2 has also shown that several amino acid
residues within the first trans-membrane domain of NS2 are
critical for assembly and release of infectious particles [19]. These
studies strongly support a role for NS2 during virus assembly.
However, the details of that role and how NS2 might act during
the production of infectious virus particles remain unknown.
Here, we show that Ala or Gly substitutions of the Ser-168
residue of NS2 impair infectious virus production without affecting
HCV RNA replication or cis-processing of the virus polyprotein.
Otherexperimentsdescribedhererevealthat the defectininfectious
virus production can be complemented in trans by expression of
wild-type NS2 protein in a genotype-specific manner, and that this
PLoS Pathogens | www.plospathogens.org 1 May 2009 | Volume 5 | Issue 5 | e1000403defect in virus production occurs at a step late in the process of viral
assembly and egress, after the interaction of core and NS5A with
host cell lipid droplets and the formation of rapidly sedimenting,
core-protein containing particles.
Results
Ala (or Gly) substitutions of NS2 Ser-168 impair
production of infectious virus without affecting RNA
replication
As indicated above, previous studies suggest that NS2 is likely to
have a role in virus assembly and/or release that is distinct from its
role during polyprotein processing and genome-amplification as
an auto-protease [12,14,19–22]. Proteins are often modulated by
phosphorylation to regulate multiple functions and, since it has
been reported that NS2 may be phosphorylated by the host cell
kinase CK2 [23], we set out to determine whether NS2
phosphorylation influences the production of infectious HCV
particles in cell culture. To this end, we mutated the Ser-168
residue in NS2, which is putatively targeted by CK2 for
phosphorylation [23], in two different infectious HCV cDNA
clones, one derived from the genotype 2a JFH1 virus, and the
other a chimeric genome (HJ3-5) which is comprised of the core-
NS2 sequence of the genotype 1a H77 virus in the background of
JFH1 with compensatory mutations in E1 (E1-Y170H) and NS3
(NS3-Q221L) [14,16]. The resulting mutants were named
JFH1(SA) and HJ3-5(SA), respectively (Figure 1A). Synthetic
RNA derived from either of the parental cDNA clones efficiently
produces infectious HCV following transfection into human
hepatoma cells (FT3-7 cells, a Huh7 sub-clone). However, the
S168A mutation completely abolished infectious virus production
by the chimeric HJ3-5 RNA, and significantly reduced the yield of
infectious virus released from cells 48 h post-transfection of JFH1
RNAs (Figure 1B). In contrast to lysates of cells transfected with
the parental RNAs, in which we could readily detect infectious
virus, only a low titer of infectious virus was present in lysates of
cells transfected with JFH1(SA) RNA; there was no infectious virus
at all in lysates of cells transfected with HJ3-5(SA) RNA, which
encodes the genotype 1a NS2 (Figure 1B). These results indicate
that Ser-168 of NS2 is involved in a step in infectious virus
production that occurs prior to the release of virus from cells.
Similar results were obtained with viral RNAs mutated to encode
a Gly residue at position 168 in NS2 (HJ3-5(SG) and JFH1(SG)
mutants, respectively) (see below).
The impaired production of infectious virus associated with the
S168A mutation was not due to an effect on genome replication,
since cells transfected with the S168A mutants accumulated HCV
RNA at a rate similar to that of wt genomes over the first 48 h
post-transfection (Figure 1C). The abundance of the S168A
mutant RNA declined after 48 h in transfected cells. In contrast,
the increase in abundance of the wt JFH1 or HJ3-5 RNA was
sustained beyond 48 h up to 96 h post transfection. This
difference in the kinetic of HCV RNA accumulation over time
between the S168A mutant and wt genomes is similar to that we
have observed previously between an assembly-defective inter-
genotypic chimeric RNA (HJ3, Figure 1A) and its derivatives, such
as HJ3-5, which are assembly competent due to a compensatory
Q221L mutation in the NS3 helicase [16]. Consistent with these
results, the S168A mutation did not impair polyprotein processing
at the NS2-NS3 junction. This was assessed by determining the
self-cleavage activity of an NS2-NS3-NS4A segment derived from
the HJ3-5 chimera, with or without the S168A mutation, following
its translation in vitro in a cell-free system (Figure 1D). Taken
together, these results indicate that the S168A mutation results in a
defect late in the virus life cycle, involving either the assembly
and/or maturation of infectious particles prior to their release
from the cell.
As discussed above, the NS2 S168 residue has been suggested to
be targeted by the host cell kinase CK2 for phosphorylation [23].
Since the results above indicate that removal of this putative CK2
target site ablates production of infectious virus, we determined
whether pharmacological inhibition of CK2 would similarly
prevent the release of infectious virus from cells transfected with
viral RNA. However, since CK2 phosphorylation of NS5A Ser-
457 is essential for infectious virus production [8], it was necessary
to first eliminate the requirement for CK2 phosphorylation at this
site. To accomplish this, we introduced an NS5A Ser-457 to Asp
mutation in both the HJ3-5 and JFH1 genomes. This mutation has
been shown to render the production of virus from a chimeric
genotype 2a RNA insensitive to pharmacologic inhibition of CK2,
or siRNA knockdown of CK2 expression [8]. These mutated
RNAs, HJ3-5/5A-S457D and JFH1/5A-S457D were transfected
into FT3-7 cells, which were then treated with a range of
concentrations of the CK2 inhibitor, DMAT (2-dimethylamino-
4,5,6,7-tetrabromo-1H-benzimidazole), from 4 to 48 h post-
transfection. As shown in Figure 1E, DMAT treatment up to
1 mM concentration had no effect on release of infectious virus by
either RNA. While we observed a .50% reduction of virus yield
by cells treated with 10 mm DMAT, this concentration of the
inhibitor causes nonspecific cytotoxicity [8]. These results are
consistent with previous findings by Tellinghuisen et al. [8]. They
suggest that CK2-mediated phosphorylation of NS2 Ser-168
residue is not essential for the production of infectious virus, and
that there is an alternative explanation for the impact of the S168A
(or S168G) mutation on this process.
Expression of NS2 from VEE vectors reveals a genotype-
specific difference in NS2 stability that is partially
reversed by MG132 inhibition of the proteasome
To characterize this defect in virus assembly, we designed a series
of experiments aimed at determining whether the S168A assembly
defect can be complemented in trans by wt NS2 expressed from an
alphavirus replicon. Toward that end, we constructed subgenomic
Venezualan equine encephalitis virus (VEE) replicons with dual
sub-genomic promoters that mediate the expression of NS2 and
drug selection marker puromycin N-acetyltransferase (PAC) [24].
Author Summary
Worldwide, more than 200 million people are chronically
infected with hepatitis C virus (HCV) and thus at risk for
fatal liver disease. New, virus-specific therapies are under
development by the pharmaceutical industry that target
aspects of virus entry and genome replication. However,
the process of viral assembly and release from the cell
remains cloaked in mystery and thus difficult to target for
drug development. Here we describe studies that reveal a
previously unrecognized role for the nonstructural protein
2 (NS2) of HCV during a late step in this process. We show
that mutations in the carboxy-terminal domain of NS2
disrupt a maturation step that is required to convert a viral
assembly intermediate to a fully infectious virus particle.
Additional genetic evidence suggests that this maturation
step occurs in concert with another nonstructural protein,
NS5A. This study thus sheds new light on the role of
nonstructural proteins in assembly and maturation of
infectious HCV particles and suggests new targets for drug
development.
HCV NS2 and Virion Maturation
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expressing the genotype 1a H77 NS2 (Flag-H77-NS2), genotype 2a
JFH1 NS2 (Flag-JFH1-NS2), and a chimeric NS2 (Flag-H/J-NS2)
comprising N-terminal H77 sequence and C-terminal JFH1
sequence fused at a site of natural recombination [14,16,25]
(Figure 2). These NS2 proteins were fused to a Flag or Myc tag at
their N-terminus, while a fourth construct, sig-H77-NS2-Flag,
included the upstream NS2 signal sequence (sig) and was fused to a
Flag tag at its C-terminus. We also constructed similar replicons
containingthe S168A orS168GmutationsinNS2.FT7-3 cellswere
transfected with each of the VEE replicon RNAs, and stable cell
lines were selected in the presence of puromycin.
Figure 1. A single mutation in NS2 disrupts infectious virus production without affecting viral RNA replication. (A) Structure of the
chimeric HJ3-5 and JFH1 HCV RNAs. HJ3-5 has two compensatory mutations, located within the E1 (YH) and NS3 (QL) sequences from its HJ3 parent
[14]. Also shown is the HJ2 chimera, in which the NS2 protein is itself chimeric. The H77 sequence is represented by the shaded boxes, while the JFH1
sequence is open. The location of the putative CK2 phosphorylation site and the S168A mutation within NS2 is highlighted. (B) Infectious virus titers
present in supernatant fluids and cell lysates 2 days following transfection of FT3-7 cells with the JFH1 and HJ3-5 RNAs, with (‘‘SA’’) or without (‘‘wt’’)
the S168A mutation. The limit of detection of infectious virus, determined in a replication focus-forming assay (10 FFU/ml), is indicated by the dashed
line. (C) Replication of HJ3-5 (left panel) and JFH1 (right panel) RNAs with or without the SA mutation. ‘‘GND’’ represents a mutant genome defective
in RNA replication due to the mutation of GDD to GND within NS5B polymerase active site. Viral RNA abundance was measured by quantitative RT-
PCR assay of 100 ng of total RNA derived from cell lysates harvested at 4, 24, 48, 72, and 96 h following transfection of the indicated RNA into FT3-7
cells. The data represent a triplicate analysis, 6S.D. (D) Auto-processing of the NS2-NS3 junction site in NS2-NS3-NS4A polyprotein segments
translated in vitro in reticulocyte lysates programmed with wt versus the S168A mutant HJ3-5 RNA. The organization of the proteins translated in
vitro are shown at the top. Below are shown the protein products of in vitro translation reactions (15–120 min reaction time), separated by SDS-PAGE.
There was no difference in the rate of generation of the mature NS2 protein over time in the presence or absence of the SA mutation. (E) Treatment
with sub-toxic concentrations of the CK2 inhibitor DMAT does not reduce virus yields from JFH1 or HJ3-5-transfected cells. In addition to the
presence or absence of the NS2 SA mutation, the RNAs transfected in this experiment each contained an S457D mutation in NS5A, which eliminates
the need for CK2 phosphorylation of this viral protein. The inhibitor was added to the media from 4 to 24 h post-transfection; virus yields were
determined by titration of supernatant fluids collected at 48 h.
doi:10.1371/journal.ppat.1000403.g001
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replicon cells suggested that there is an intrinsic difference in the
stability of the wt H77 and JFH1 NS2 proteins. In multiple
attempts to establish stable VEE replicon cell lines, the abundance
of JFH1 NS2 was always greatest, followed by the chimeric H/J-
NS2, and then H77 NS2 (Figure 2B). Similar results were obtained
whether the NS2 proteins were fused to either a Flag or Myc tag at
the N-terminus. Franck et al. [23] reported previously that the NS2
protein expressed by the genotype 1a HCV-H strain (which is
closely related to the H77 virus) is unstable, and that its abundance
could be increased by treatment with the proteasome inhibitor,
MG132. This suggests that the genotype 1a NS2 protein may be
degraded in a proteasome-dependent fashion. Franck et al. [23]
also showed that the S168A mutation enhances the stability of
HCV-H NS2. Consistent with this, we observed that the S168G
mutation modestly increased the abundance of the H77 NS2
protein expressed from VEE replicons (Figure 2C, compare lanes
3 versus 5). MG132 treatment of VEE replicon cell lines
significantly enhanced the abundance of the wt H77 NS2 and,
to a lesser extent, the related S168G mutant (lanes 3 versus 4 and 5
versus 6). This was the case with both N- and C-terminally Flag-
tagged proteins, whether or not the upstream signal sequence was
expressed with NS2 (lanes 1 versus 2). However, it had no effect on
the abundance of the JFH1 NS2 protein (lanes 7 versus 8).
Inclusion of the S168G mutation also did not enhance JFH1 NS2
abundance (data not shown).
Interestingly, MG132 treatment resulted in the appearance of a
,14 kDa NS2 degradation product in cells containing the wt
Flag-H77-NS2 replicon, while this was not observed with cells
expressing wt JFH1 NS2 (lanes 4 versus 8). The H77 NS2
degradation product was derived from the N-terminus of NS2,
since it was detected in Flag immunoblots only when Flag was
fused at the N-terminus of NS2 (Flag-H77-NS2) and not the C-
terminus (sig-H77-NS2-Flag) (lanes 4 versus 2). Moreover, it was
not detected in MG132-treated cells expressing the H77 S168G
mutant, Flag-H77-NS2(SG) (lanes 4 versus 6). A similar degrada-
tion product was not detected in cells expressing wt JFH1 NS2
upon MG132 treatment (lane 8). These results suggest that the
H77 NS2 protein is intrinsically less stable than JFH1-NS2,
probably because it is more prone to proteasome-mediated
degradation. They also suggest the possibility that H77-NS2
undergoes a cleavage event leading to a ,14 kDa fragment that is
degraded by the proteasome. Importantly, the S168G mutation
appears to prevent that cleavage and stabilize the H77 NS2
protein. While pulse-chase experiments and experiments to
determine whether the H77 NS2 molecule is ubiquitinated are
ongoing, these results indicate important differences in stability of
the H77 and JFH1 NS2 proteins that may in part explain the
difference in the impact of the S168A mutation on infectious virus
production by the JFH1(SA) and HJ3-5(SA) RNAs shown in
Figure 1B.
Wild-type NS2 trans-complements the S168A defect in
virus production in a genotype-specific manner
To ascertain the potential for trans-complementation of the
S168A-imposed defect in virus assembly, we transfected the
JFH1(SA) and HJ3-5(SA) RNAs into the NS2-expressing cell lines
shown in Figure 2 and monitored release of infectious virus into
the extracellular milieu. The presence of a replicating VEE
replicon had no effect by itself on the assembly-defective
phenotype of the S168A JFH1 mutant, as there was no difference
in the extracellular virus yield when the JFH1(SA)-mutant RNA
was transfected into the parental FT3-7 cells or cells containing a
control, green fluorescent protein (GFP)-expressing VEE replicon
(VEE-GFP) (Figure 3A). When JFH1(SA) RNA was transfected
into cells expressing Flag-JFH-NS2, the JFH1 infectious virus yield
was increased over 10-fold compared to normal FT3-7 cells and
restored to the level observed in cells transfected with wt JFH1
RNA (Figure 3A). Transfection of the JFH1(SA) mutant into
replicon cells expressing the wt H77 NS2 resulted in no increase in
infectious virus production (Figure 3A). Expression of either the N-
Figure 2. Stability of NS2 proteins expressed by subgenomic
VEE replicons. (A) At the top is shown the organization of
subgenomic VEE replicons expressing the H77, JFH1, and chimeric
HJ2 (‘‘H/J’’) NS2 protein. Arrows indicate the VEE subgenomic promoter,
while ‘‘Pac’’ indicates the puromycin resistance gene. Shown below are
the different NS2 proteins expressed by this series of replicons; each
contains either an N- or C-terminal Flag (or Myc) tag. (B) Immunoblot
detection of NS2 protein using anti-Flag (left panel) or anti-Myc (right
panel) antibodies. With the exception of sig-H77-NS2-Flag, which has a
Flag tag at the C-terminal end of the NS2 protein, all of the other NS2
proteins have a Flag or Myc tag at the N-terminus. (C) Treatment with
the proteasome inhibitor MG132 enhances the abundance of H77 NS2
(both wt and to a lesser extent the S168G mutant, ‘‘SG’’) but not JFH1
NS2 expressed by VEE replicon cell lines.
doi:10.1371/journal.ppat.1000403.g002
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production of infectious virus by cells transfected with HJ3-5(SA)
RNA, resulting in a greater than 100-fold increase in infectious
virus yields (Figure 3B). Although VEE replicon cells expressing
JFH-NS2 also promoted virus production by the HJ3-5(SA) RNA,
the virus yield was only 10% that obtained in the Flag-H77-NS2
expressing cells, even though Flag-JFH-NS2 protein expression
was much higher (Figures 2 and 3B). VEE replicon cells expressing
JFH1-NS2(SA) or H77-NS2(SA) were unable to support the
production of virus by JFH1(SA) or HJ3-5(SA) RNA, respectively,
confirming that functionally active NS2 protein is required for the
trans-complementation of virus production (Figure 3A and 3B). In
aggregate, these results indicate that expression of wt NS2 is
capable of trans-complementing an NS2-specific defects, and that
this trans-complementation activity is genotype-, or possibly strain-
specific.
A compensatory mutation in the N-terminal region of the
chimeric H/J-NS2 enhances infectious virus production in
trans
We next assessed the ability of the chimeric H/J-NS2 protein to
trans-complement the virus assembly defect in the JFH1(SA) and
HJ3-5(SA) mutants. As shown in Figure 4C and 4D, cells
expressing the chimeric (H/J)-NS2 were capable of supporting
the production of infectious virus by either JFH1(SA) or HJ3-5(SA)
RNA,although to a lesser extent than cells expressing the
homologous JFH1 or H77 NS2.
We previously reported that several naturally evolving com-
pensatory mutations in the N-terminal domain of NS2 enhanced
the production of infectious virus (but not viral genome
replication) by a chimeric HCV genome (H-(NS2)-J RNA, referred
to herein as HJ2) [14], in which sequence encoding the structural
proteins of the genotype 1a H77 virus had been placed within the
context of the JFH1 genome, and in which the NS2 protein was
identical to the H/J-NS2 chimera expressed by the VEE replicons
(Figure 1A). To determine whether the positive effect of these
compensatory NS2 mutations could be re-created in the trans-
complementation system, we constructed a VEE replicon
expressing H/J-NS2 containing one such mutation, NS2 I30T
(I839T in the H77 polyprotein sequence). Cells expressing this
mutated chimeric NS2 (Myc-H/J-NS2-I30T) produced a 6- to 8-
fold higher yield of infectious virus when transfected with HJ3-
5(SA) RNA, compared to cells expressing the chimeric NS2
without the compensatory mutation (Figure 4D). Significantly, the
presence of this mutation had no effect on the efficiency of virus
production in cells transfected with the JFH1(SA) RNA
(Figure 4C), again indicating the genotype- (or strain-)specific
nature of trans-complementation.
In aggregate, these data indicate that both the N-terminal and
C-terminal domains of NS2 are somehow involved in processes
required for production of infectious virus particles. Of note,
however, is that our prior work suggests that the NS2 I30T
mutation does not influence assembly per se, but rather enhances
the specific infectivity of released virus particles, suggesting an
effect on a late, post-assembly maturation step [14].
The C-terminal domain NS2 is essential for trans-
complementation of virus production
To better define the NS2 domains required for trans-comple-
mentation of S168A-mediated defect in virus production, we
constructed a series of VEE replicons expressing H77-NS2 protein
mutants with N- and C-terminal deletions of increasing length.
Figure 3. Genotype-specific trans-complementation of the NS2 S168A-mediated defect in infectious virus production. (A) Extracellular
virus yields (FFU/ml) determined three days after transfection of JFH1 RNA, with or without the S168A mutation (‘‘SA’’), into normal FT3-7 cells or VEE
replicon cells expressing GFP, Flag-JFH1-NS2, Flag-JFH1-NS2/SA, or Flag-H77-NS2. (B) Extracellular virus yields (FFU/ml) determined in a similar fashion
following transfection of the HJ3-5 RNA with or without the S168A mutation into normal FT3-7 cells, or VEE replicon cells expressing GFP, the
homologous NS2 sequence with or without the SA mutation, or the heterologous wild-type NS2 sequence (sig-H77-NS2-Flag, Flag-H77-NS2, Flag-
H77-NS2/SA, or Flag-JFH1-NS2 replicon cells).
doi:10.1371/journal.ppat.1000403.g003
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expression could not be detected by immunoblotting or immuno-
fluorescence microscopy (even with MG132 treatment) in cells
transfected with the replicons (data not shown). However, the C-
terminal deletion mutants were expressed at an abundance similar
to that of the wt protein (Figure 5A and 5B). Nonetheless, when
the HJ3-5(SA) mutant RNA was transfected into VEE replicon
cells expressing these C-terminal deletion mutants, none were
capable of trans-complementing the S168A defect in virus
production. These data indicate that NS2 contains an essential
domain within its C-terminal 71 residues that is required for
production of infectious virus particles, consistent with the
phenotype of the S168A and S168G mutants.
The NS2 S168G mutation does not prevent assembly of
fast-sedimenting core-containing particles, suggesting a
defect late in infectious virus production
As described previously, the chimeric HJ3-5 RNA used in the
experiments described above does not produce infectious virus
particles in the absence of one or more compensatory mutations
within the NS3 helicase domain (Q221L in HJ3-5, Figure 1A).
These NS3 mutations are required for the intracellular assembly of
core protein-containing particles that have the sedimentation
properties of infectious virions [14,16]. The ability of these
mutations to compensate for the assembly defect in the parental
chimeric RNA (H-(NS2/NS3)-J, referred to herein as HJ3)
(Figure 1A), has thus defined an important role for NS3 during
an early step in infectious virus production that involves particle
assembly [14,16]. To ascertain whether the Ala or Gly substitution
at Ser-168 of NS2 causes a similar early defect in particle
assembly, or acts at a later, post-assembly step, we characterized
the sedimentation properties of core protein present in extracts of
HJ3-5 and HJ3-5(SG) RNA transfected cells. This was accom-
plished by rate-zonal centrifugation of cell extracts in sucrose
gradients, followed by immunoblotting individual gradient frac-
tions to detect the presence of the core protein. These experiments
were carried out in cells containing the GFP- or H77-NS2-
expressing VEE replicon. Results were compared with those from
cells transfected with the assembly-defective HJ3 chimeric RNA as
a control.
Results from this series of experiments are shown in Figure 6A.
Consistent with previously reported data [16], peak core protein
abundance was found in fractions 6–12 (from the top) of gradients
loaded with extracts of HJ3-transfected cells (‘‘slow sedimenting’’)
(Figure 6A, lower panel). In contrast, the bulk of the core protein
present in lysates of cells transfected with HJ3-5 (which contains
the compensatory Q221L mutation) sedimented more rapidly, and
was present in gradient fractions 12–19 (‘‘fast sedimenting’’) [16].
These latter fractions also contained the peak HJ3-5 infectious
virus titer (HJ3 produces no infectious virus) (Figure 6A, upper
panel). Importantly, although some core was found at the very top
of the gradient (fraction 1), a significant portion of the core protein
present in lysates of GFP-expressing cells transfected with HJ3-
5(SG) RNA was also present in fractions 12–19 (Figure 6A). This
result indicates that the S168G mutation does not prevent the
assembly of fast-sedimenting virus-like particles, despite the
absence of infectious virus production. Thus, the S168G mutant
appears to be defective in a late, post particle-assembly step, in
virus production.
Despite the assembly of core into fast-sedimenting intracellular
particles, we were not able to detect the release of a measurable
amount of core protein from cells transfected with the HJ3-5(SG)
mutant using a sensitive ELISA assay (Figure 6B). In contrast, core
protein was readily detected in supernatant media from cells
transfected with the parental HJ3-5 RNA (Figure 6B). Taken
together with the results shown in Figure 6A, these results suggest
that at least one of the functions of NS2 protein is to confer
infectivity to pre-assembled core containing particles, and that in
Figure 4. The I30T mutation in NS2 enhances the efficiency of trans complementation in a genotype-specific manner. (A) Organization
of the chimeric H/J-NS2 replicon expression product, showing the location of the compensatory I30T mutation in the H77-derived sequence [14,36].
See also Figure 2A. (B) Immunoblot detection of NS2 protein using anti-Myc antibodies. (C,D) Infectious virus yields after transfection of (C) JFH1(SA)
or (D) HJ3-5(SA) RNA into VEE replicon cells expressing GFP, or Myc-H/J-NS2 with or without the I30T mutation. Extracellular virus yields were
determined three days following transfection. The detection limit of the infectivity assay is indicated by the broken line.
doi:10.1371/journal.ppat.1000403.g004
HCV NS2 and Virion Maturation
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particles are prevented from being released from the cell.
Consistent with this interpretation, the amount of core protein
present in lysates of cells transfected with the S168G mutant was
over 10-fold the limit of detection in the ELISA assay, and thus at
least 10-fold greater than the abundance in the supernatant fluids
(Figure 6B). In contrast, the concentration of core was slightly
greater in the supernatant fluids than in extracts from the HJ3-5
transfected cells. Gastaminza et al. [26] recently demonstrated that
high density, infectious, intracellular HCV particles are prone to
degradation in a proteasome-independent manner unless they
undergo a maturation step that is necessary for secretion [26]. The
data shown in Figure 6A and 6B are consistent with this model for
virus production, and suggest that NS2 plays a key role in the
transition from non-infectious, intracellular particles to infectious
particles capable of secretion.
When we similarly analyzed lysates of H77-NS2 expressing
replicon cells transfected with the HJ3-5(SG), we found that the
infectious virus produced by trans-complementation banded within
fractions 12–19, similar to virus produced by the parental HJ3-5
RNA in GFP-expressing cells (Figure 6A, upper panel). Consistent
with these results, a significant proportion of the core protein was
also detected in these fractions (Figure 6A, lower panel). However,
a substantial amount of the core protein also sedimented slowly
(fractions 3–11), consistent with the relatively low efficiency of
trans-complementation and the 40-fold lower titer of infectious
virus produced compared with wt HJ3-5 RNA (see legend to
Figure 6A). We observed similar results, including a substantial
proportion of core protein within fractions 12–19, when we
analyzed lysates of VEE H77-NS2(SG) replicon cells transfected
with the HJ3-5(SG) RNA (Figure 6A, bottom panel). These results
provide compelling evidence that the NS2 S168G mutation does
not prevent the assembly of rapidly-sedimenting, core-containing
particles despite the inability of RNA bearing this mutation to
produce infectious virus. While the distribution of the rapidly
sedimenting core antigen associated with the noninfectious
particles that formed in the HJ3-5(SG) RNA-transfected cells
across fractions 12–19 of these gradients was very similar to the
distribution of core associated with the infectious particles formed
in cells transfected with the assembly-competent HJ3-5 RNA,
these experiments do not exclude significant differences in the
composition of these particles.
To further characterize the non-infectious and trans-comple-
mented, infectious HJ3-5(SA) particles, we ascertained their
buoyant density by equilibrium centrifugation of cell lysates in
iodixanol density gradients and compared these results with
intracellular HJ3-5 particles. As shown in Figure 6C, the densities
of the infectious intracellular particles derived from the HJ3-5 and
trans-complemented HJ3-5(SG) RNA were indistinguishable, with
peak infectivity for each banding between 1.104 and 1.121 g/cm
3.
Most of the core protein present in these lysates banded at the
same density as infectious particles, while lesser amounts were
found in less dense fractions (1.028–1.047 g/cm
3) (Figure 6C).
Very similar results were obtained in immunoblots of fractions
from gradients loaded with the non-infectious HJ3-5(SG) particles.
These results indicate that the buoyant density of the non-
infectious HJ3-5(SG) particle is similar to the infectious particles
produced by trans-complemented HJ3-5(SG) RNA and the
parental HJ3-5 genome, despite the absence of infectivity.
The NS2 S168G mutation does not alter the co-
localization of core and NS5A on lipid droplets
Recent reports indicate that the NS5A protein plays a critical
role in the assembly of HCV particles by recruiting replication
complexes to core protein localized on the surface of lipid droplets
where particle assembly takes place [9,10,27]. Since the results
shown in Figure 6 suggest that the mutations in Ser-168 of NS2
impact a later, post-assembly step in the production of infectious
virus, we considered it likely that these mutations would not
interfere with the association of NS5A with the core protein on
lipid droplet, despite the ability of the mutations to ablate
infectious virus production from HJ3-5 RNA. This was confirmed
by laser-scanning confocal microscopy of FT3-7 cells transfected
with the HJ3-5 or HJ3-5(SG) RNAs, which revealed co-
localization of core and NS5A protein on lipid droplets in cells
transfected with either RNA (Figure 7A). Thus, the NS2-S168G
mutation has no impact on the interaction of core with NS5A on
lipid droplets. This is consistent with the rate-zonal gradient
analysis shown in Figure 6A, which indicates that replication of the
HJ3-5(SG) RNA leads to the assembly of core protein-containing
particles with sedimentation properties similar to the infectious
virus particles produced from the wt genome. The colocalization
of core and NS2 on lipid droplets was unchanged when the HJ3-
5(SA) mutant RNA was transfected into cells containing a replicon
expressing JFH1-NS2 (Figure 7B).
Figure 5. C-terminal deletion mutants of NS2 are incapable of
complementing the S168A defect in virus production. (A) NS2 C-
terminal deletion mutants expressed by modified VEE-Flag-H77-NS2
replicons. The black and grey shaded areas indicate four potential
transmembrane domains within NS2 that have been reported
previously [18]. The grey sequence area needs to be located within
the cytoplasm to function as part of the NS2-NS3 protease [20]. The
position of Ser-168 is indicated. (B) Immunoblots of full-length and C
terminally truncated versions of the H77 NS2 protein expressed by the
VEE replicon cell lines. (C) Extracellular infectious virus yields
determined three days after transfection of the mutant HJ3-5(SA) RNA
into the VEE replicon cell lines expressing wt and C-terminal deletion
mutants of H77 NS2.
doi:10.1371/journal.ppat.1000403.g005
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PLoS Pathogens | www.plospathogens.org 7 May 2009 | Volume 5 | Issue 5 | e1000403Figure 6. Detection of fast-sedimenting, core-containing HJ3-5(SG) particles with physical properties similar to infectious virus. (A)
Rate zonal centrifugation of cell lysates derived from VEE replicon cell lines expressing GFP, Flag-H77-NS2, or Flag-H77-NS2(SG) following transfection
with the HJ3, HJ3-5, and HJ3-5(SG) RNA. A total of 40 fractions were collected from each gradient: the titer of infectious virus in fractions from HJ3-5
transfected cells was reduced in scale 40-fold to allow it to be plotted on the same graph as the trans-complemented infectious particles present in
lysates of Flag-H77-NS2 cells transfected with the mutant HJ3-5(SG) RNA. Cell lysates were prepared three days following transfection by multiple
rounds of freeze-thawing. The top panel shows the sedimentation profile of infectious HJ3-5 and trans-complemented HJ3-5(SG)-derived particles.
The bottom panel shows immunoblot detection of core protein in fractions 1–20 of the gradients. The fractions containing the peak infectivity are
indicated with dashed lines. Slow-sedimenting core antigen was present in fractions 6–13, while fast-sedimenting particles were found in fractions
14–19. (B) Core antigen measured by a quantitative ELISA assay in cell lysates or supernatant fluid from FT3-7 cells transfected with HJ3-5 RNA, with
or without the S168G mutation. (C) Equilibrium density gradient ultracentrifugation of particles present in VEE replicon cell lysates expressing GFP or
Flag-H77-NS2, three days post-transfection of the HJ3-5 or HJ3-5(SG) RNA. Infectious virus titer of each fraction is shown in the top panel, with the
scale reduced 80-fold for HJ3-5 to allow it to be plotted in the same graph as the trans-complemented HJ3-5(SG) –derived virus. The relative
distribution of core antigen present in each gradient fraction, as determined by immunoblotting, is shown in the lower panel.
doi:10.1371/journal.ppat.1000403.g006
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NS5A, but not with core
Confocal microscopy also demonstrated that the Flag-JFH1-
NS2 protein expressed from VEE replicons was distributed in a
reticular pattern throughout the cytoplasm, but with particularly
strong staining near the nuclear membrane (Figure 8A and 8B).
Flag-H77-NS2 showed a similar distribution (data not shown), but
a much lower signal intensity consistent with lower protein
abundance determined in immunoblots (Figure 2). Since an
assembly-defective core mutant was recently shown to be rescued
by a second-site mutation within NS2 [15], we used confocal
microscopy to determine whether there was co-localization of
these two proteins in VEE Flag-JFH1-NS2 replicon cells
transfected with the HJ3-5(SA) RNA. As shown above, the
expression of the JFH1 NS2 protein in these cells rescues the
ability of the HJ3-5(SA) RNA to produce infectious particles
(Figure 3B). However, there was no demonstrable co-localization
of NS2 and core in these cells (Figure 8A, upper panels), nor in
JFH1 NS2-expressing cells transfected with JFH1(SA) RNA
(Figure 8B, upper panel).
The reticular staining pattern observed for NS2 in these studies
resembles that of E1 and E2, which localize to the ER membrane
[28]. Consistent with this, there was strong co-localization of E2
and NS2 when the Flag-JFH1-NS2 replicon cells were transfected
with either HJ3-5(SA) or JFH1(SA) (Figure 8A and 8B, middle
panels). This was confirmed by a quantitative pixel analysis of
these confocal microscopic images (see the panels to the right in
Figure 8A and 8B). Since most E2 protein does not co-localize
with core in JFH1 infected cells [28], the co-localization of NS2
with E2 is consistent with the absence of co-localization with core.
Quantitative pixel analysis also suggested partial co-localization of
NS2 with NS5A in these experiments, but to a lesser extent than
with E2 (we used Myc-JFH1-NS2 replicon cells in this experiment,
as this allowed simultaneous labeling of NS5A with rabbit
antibody and NS2 with murine anti-Myc) (Figure 8A and 8B,
lower panels). Taken together, these results suggest that NS2 and
E2 localize to membranes of the peri-nuclear ER, distinct from
core which strongly localizes to the lipid droplet. NS5A associates
with core on the lipid droplet, but also is found in association with
NS2, a fact that may be important in particle assembly.
Second-site mutations in NS2 and NS5A rescue the NS2
S168G-mediated defect in production of infectious virus
To better understand how Ser-168 might function to confer
infectivity on pre-assembled HCV particles, we transfected cells
with the HJ3-5(SA) RNA and attempted to isolate revertants with
second-site mutations capable of rescuing the ability of the HJ3-
5(SA) RNA to produce infectious virus. In multiple transfection
experiments, infectious virus began to be released from cells after
6–7 cell passages. However, sequencing of RNA extracted from
these viruses invariably revealed reversion of the S168A mutation
to the wt sequence (a single nucleotide change is sufficient).
Figure 7. Mutation of NS2 S168 does not perturb the co-localization of core and NS5A on the lipid droplet. (A) FT3-7 cells were
transfected with HJ3-5 or HJ3-5(SG) RNA, and two days later washed and fixed, as described in Materials and Methods, then labelled with antibodies
specific for core protein (green) and NS5A (red) followed by examination with a Zeiss LSM 510 Meta microscope. Neutral lipid staining is shown in
blue. At the right is an enlarged area from the merged image showing enlarged views of solitary lipid droplets (see box). (B) HJ3-5(SA) RNA was
transfected into the VEE replicon cell line expressing FlagJFH1-NS2. The intracellular localization of core and NS5A was determined as described in (A).
doi:10.1371/journal.ppat.1000403.g007
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nucleotide substitutions are required to change the codon (‘GGG’)
from Gly back to Ser. We successfully isolated revertants in 4
independent transfection experiments, with release of infectious
virus first detected between cell passages 7 to 11 (Table 1).
Sequencing of these viruses revealed mutations at Leu-174 of NS2
in 3 out of 4 independent transfection experiments: this residue
was changed to Val in 2 experiments, and to a mixture of Leu and
Ile in the third experiment, in concert with a mixture of Trp and
Arg at Arg-68 in the protease domain of NS3. (The HJ3-5(SG)
clone used in these experiments was found subsequently to contain
an adventitious NS5A mutation, Thr-115 to Ala; this had partially
or completely reverted to the wild-type Thr sequence in virus from
each of these 3 transfection experiments). The only mutation
found in infectious virus recovered from the fourth transfection
experiment was in NS5A, in which Val-464 was changed to Leu.
These mutations are summarized in Table 1.
To confirm that these mutations render the HJ3-5(SG) RNA
capable of producing infectious virus, we independently intro-
duced the NS2-L174V and NS5A-V464L mutations into the HJ3-
5(SG) construct (resulting in HJ3-5(SG)/2-L174V and HJ3-5(SG)/
5A-V464L, respectively) and assessed the ability of the modified
RNAs to produce infectious virus by measuring infectivity in
supernatant fluids 2 days after transfection. The NS2-L174V
mutation, which is only 6 residues distant from the S168G
mutation in HJ3-5(SG), resulted in robust production of infectious
virus, fully restoring the ability of the HJ3-5(SG) RNA to produce
infectious virus (Figure 9). Interestingly, the JFH1 NS2 protein
already contains Val at residue 174. Therefore, it is tempting to
speculate that the lesser inhibition of virus production we observed
when we placed the S168A mutation in the JFH1 compared to the
HJ3-5 background (Figure 1B) may reflect this natural polymor-
phism.
The NS5A-V464L mutation also restored the ability of the HJ3-
5(SA) RNA to produce infectious virus. However, although the
NS5A-V464L mutation enhanced virus production at least 1000-
fold, infectious virus yields from the HJ3-5(SG)/5A-V464L RNA
were about 10-fold less than with wt HJ3-5 RNA (Figure 9). This
genetic interaction between NS2 and NS5A is consistent with a
direct physical interaction of the two proteins as suggested by the
partial co-localization of NS2 and NS5A detected by confocal
microscopy (Figure 8A and 8B, lower panels). Interestingly, the
V464L mutation is close to a putative CK2 phosphorylation site in
the C-terminal domain of NS5A (Ser-457) that regulates the
production of infectious JFH1 virus [8]. It also has been identified
during selection of JFH1 variants capable of producing higher
yields of infectious virus in cell culture [29].
Discussion
NS2 is a small trans-membrane protein that is located between
the structural and nonstructural proteins within the HCV
polyprotein [17,18]. Until recently, the only known role for this
protein in the viral life cycle was its auto-protease activity, which
cleaves the polyprotein between NS2 and NS3 [20,22,30].
However, along with newly recognized roles for two other
nonstructural proteins, notably NS5A [8–10] and NS3 [16], in
viral particle assembly, there is growing evidence that NS2 also has
essential function(s) that are required for the production of
infectious virus [12,14,15,19]. In the work described here, we
have shown that a highly conserved amino acid residue within
NS2 (Ser-168) is essential for the production of infectious virus
particles, as the mutation of this residue to Ala or Gly either
eliminated or substantially reduced the yield of infectious virus
Table 1. Mutations identified in infectious HJ3-5(SG) pseudo-
revertants.
Protein Parent Clone Exp. #1 Exp. #2 Exp. #3 Exp. #4
NS2 Leu-174 Ile* Val Val
NS3 Arg-68 Trp*
NS5A Ala-115
{ Thr* Thr Thr
NS5A Val-464 Leu
*Present as a mixture with parental sequence.
{Adventitious mutation in the parental clone.
doi:10.1371/journal.ppat.1000403.t001
Figure 9. Second-site mutations in NS2 or NS5A rescue
infectious virus production by HJ3-5(SG) RNA. Extracellular virus
yields were determined two days post-transfection of FT3-7 cells with
the indicated RNAs. Results shown represent the average from two
independent experiments.
doi:10.1371/journal.ppat.1000403.g009
Figure 8. Confocal microscopic imaging of intracellular NS2 distribution. NS2 protein co-localizes with E2 but not core protein. VEE replicon
cells expressing FlagJFH1-NS2 were transfected with (A) HJ3-5(SA) or (B) JFH1(SA) RNA and fixed and labeled two days later with antibodies specific
for core protein (green, upper panel), E2 (green, middle panel), NS5A (green, lower panel), or NS2 (red). Slides were subsequently examined with a
Zeiss LSM 510 Meta microscope. At the right are line scan results obtained using MetaMorph software depicting a linear trace of the fluorescence
intensity of individual pixels along a segment of the white arrow overlaying the merged image. The Y axis represents average pixel intensity while the
X axis represents distance from the origin. Red, green, and blue traces correspond to the color of the fluorophores shown in merged images. This
analysis revealed a high level of colocalization between NS2 and E2, but only partial colocalization of NS2 and NS5A.
doi:10.1371/journal.ppat.1000403.g008
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encoding either genotype 1a or 2a NS2 protein (Figure 1B).
Furthermore, we show that the defect in infectious virus
production that is caused by mutation of Ser-168 is within a late
step in this process, one that occurs subsequent to the assembly of
core-protein containing particles, as non-infectious, intracellular
particles with sedimentation properties and buoyant densities
similar to infectious virus still formed within cells transfected with
the mutant RNAs (Figure 6A). Consistent with this, core and
NS5A proteins were co-localized, as they normally are, on the
surface of lipid droplets in HJ3-5(SG) transfected cells (Figure 7A).
Thus, the defect imposed by the Ser-168 mutations appears be
within a maturation step that confers infectivity on previously
assembled particles. Since the non-infectious, core-containing
particles that are assembled by these NS2 mutants are not released
from the cell (Figure 6B), this maturation process may be required
for their release from the cell. The data presented here thus reveal
a novel role for NS2, most likely in cooperation with NS5A (see
below), during the maturation of HCV particles late in the process
of virus assembly and release.
Our focus on the Ser-168 residue in NS2 was prompted by the
report of Franck et al. [23], who suggested that this residue (in the
genotype 1a HCV-H strain of HCV) is targeted by the host kinase,
CK2, for phosphorylation. However, although we found that both
S168A and S168G mutations ablated production of infectious
virus by HJ3-5 RNA (which contains NS2 sequence from H77)
(Figure 1B), the lack of a specific effect of DMAT on production of
infectious virus by this RNA strongly suggests that phosphorylation
of Ser-168 by CK2 is not required for this process (Figure 1E).
These latter data are consistent with recent work by Tellinghuisen
et al. [8], who identified a CK2 phosphorylation site in NS5A and
reported that treatment with a CK2 inhibitor did not impair
infectious virus release by a genotype 2a RNA (J6/JFH1 chimera)
provided the NS5A residue targeted by CK2 was first mutated to
Asp. Importantly, we found that mutations at NS2 Ser-168
significantly impaired infectious virus production by viral RNAs
containing either the genotype 1a (HJ3-5) or 2a (JFH1) NS2A
sequence. Taken together, these data suggest that the NS2 Ser-168
mutations are likely to inhibit the production of infectious virus by
a mechanism other than interference with CK2 phosphorylation
of this residue.
As described by Franck et al. [23], we observed that the
genotype 1a H77 NS2 protein was subject to proteasome-
mediated degradation (Figure 2). While Franck et al. suggested
that CK2 phosphorylation of Ser-168 regulates the stability of the
H77 NS2 protein, our data suggest that the protein is partially, but
not completely, stabilized by a Gly substitution at this residue
(Figure 2C). In contrast, the wt genotype 2a JFH1 NS2 does not
appear to be subject to proteasome-mediated degradation
(Figure 2C), although it shares the same putative CK2 target site,
Ser-168 in NS2, along with other HCV sequences [23]. The
difference in the intrinsic stability of the NS2 proteins from these
two distinct viral strains may account, at least in part, for the
differences we observed in the magnitude of the impact of S168A
or S168G mutations on infectious virus production by the HJ3-5
and JFH1 RNAs. The S168A mutation completely abolished
infectious virus production by HJ3-5, while causing an incomplete
loss of infectious virus yield from the JFH1 RNA (Figure 1B).
However, we also observed that the H77 NS2 could trans-
complement the production defect in HJ3-5(SA) but not JFH1(SA)
RNA, while the JFH1 NS2 can rescue virus production by either
RNA (although with a greater effect on the JFH1(SA) defect)
(Figure 3A and 3B). These differences in NS2 trans-complemen-
tation cannot be attributed simply to differences in NS2 stability,
and suggest more fundamental differences in NS2-protein
interactions required for particle maturation. Whether these
differences are restricted to these two specific strains of HCV, or
instead reflect broader, genotype-specific differences (genotype 1a
versus 2a), will require further study.
Importantly, second site mutations involving either Leu-174 in
NS2 (residue 938 in the polyprotein), or Val-464 in NS5A
(residue 2440) were capable of rescuing the defect in virus
production mediated by the S168G mutation (Figure 9). An X-
ray crystallographic reconstruction of the NS2 auto-protease
domain suggests that both Ser-168 and Leu-174 are surface-
exposed residues [20]. Therefore, it seems reasonable to speculate
that Ser-168 and Leu-174 may be involved in protein-protein
interaction(s) required for the maturation of previously assembled
particles and leading to the production of infectious virus. The
fact that the V464L mutation in NS5A also rescues infectious
virus production by the NS2 S168G mutant suggests the
possibility that this putative NS2 interaction could involve
NS5A (Figure 9). While other explanations are possible for the
genetic interaction we observed between NS2 and NS5A, a close
physical interaction is suggested by the partial co-localization of
NS2 and NS5A identified by confocal microscopy (Figure 8).
Whether or not a direct interaction occurs between NS2 and
NS5A, the rescue of the late NS2 defect in virus production by a
second-site mutation in NS5A indicates that NS5A acts at
multiple, temporally distinct points in the production of infectious
virus particles. First, in an early step in virus assembly, NS5A is
recruited to the core protein which decorates the surface of lipid
droplets [8–10]. This is a pre-requisite for particle assembly, but
it is not sufficient, as we have recently described an NS3 defect in
infectious virus production that ablates intracellular particle
assembly but does not impair the association of NS5A with core
on lipid droplets [16]. The data we have presented in this paper
indicate that NS2 acts at a later step in the process of infectious
particle production, in association with NS5A but subsequent to
the earlier involvement of core, NS5A and NS3, to confer
infectivity on previously assembled particles in a maturation step
that appears to be required for release of virus to the extracellular
environment. This hypothetical sequence for the contribution of
individual nonstructural proteins to infectious particle assembly
and release is summarized in Figure 10.
HCV is classified within the family Flaviviridae, and thus it is
related phylogenetically to yellow fever virus (YFV) as well as
Kunjin virus. It is interesting to note that the NS2A proteins of
YFV and Kunjin have also been implicated in virus assembly and
release, and in both cases this function can be trans-complement-
ed by expression of the wt protein [31,32], as we have shown here
for HCV. Although the flavivirus NS2A proteins differ substan-
tially from the NS2 protein of HCV both in sequence and
functions within the viral life cycle, it is not unreasonable to
suspect that they may share some mechanistic features in
common during the process of virus assembly and release. In
the case of the Kunjin NS2A protein, its role in infectious virus
assembly and release appears to be closely linked to the
production of specific virus-induced membrane alterations [32].
We observed very strong co-localization of the HCV NS2 protein
with the major envelope protein, E2, in VEE replicon cells during
infectious virus production (Figure 8A and 8B, middle panels). E2
and NS2 were both prominently localized to membranes of the
peri-nuclear ER, suggesting the possibility of an interaction
between NS2 and E2 during the maturation process. NS2 may
interact with E1 as well, since we showed recently that a mutation
in E1 (Y170H) functions cooperatively with a mutation in NS2
(I30T), but not P7 (Y31C), to enhance the infectious yield of virus
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Lemon SM, unpublished data). One possibility is that NS2 might
facilitate a rearrangement of the envelope proteins following
assembly of the particle that confers or enhances infectivity. Such
an envelope rearrangement would not be without precedent
among the flaviviruses, and could be required for infectivity of the
HCV particle. Additional studies of the HCV assembly and
release process will be required to assess this possibility, as well as
a detailed characterization of the structure of the infectious virus
particle.
Materials and Methods
Plasmids
The parental and chimeric HCV plasmids used in these studies
have been described previously: pHJ3-5 (pH-(NS2/NS3)-J/YH/
QL) was derived from pHJ3 (pH-(NS2/NS3)-J) by introducing two
compensatory mutations, one located within E1 (Y361H) and the
other in NS3 (Q1251L), that allow for assembly of infectious virus
particles following transfection of Huh7 cells [14,16]. The NS2
S168A mutation was introduced into the pHJ3-5 and pJFH1
plasmids resulting in pHJ3-5(SA) and pJFH1(SA) by QuikChange
mutagenesis (Stratagene) and confirmed by sequencing analysis.
Similar methods were utilized to construct and validate the NS2
S168G and the various NS5A mutants described in the text. VEE
replicons expressing various NS2 proteins were constructed using
p59VEErep/L/GFP/Pac [24], a generous gift from Dr. Ilya
Frolov (University of Texas Medical Branch at Galveston). To
facilitate these constructions, a PacI site was introduced at the end
of the GFP coding sequence in this plasmid using QuikChange
mutagenesis (p59VEErep/L/GFP/Pac v.2). NS2 coding sequence
was amplified from pH77S or pJFH1 by PCR using primers that
were designed to introduce XbaI and PacI sites at the 59- and 39-
termini of the NS2 sequence. Additional sequences encoding Flag
or Myc tags were placed at the N- or C-terminal end of NS2, as
shown in Figure 2A. The NS2 fragments were digested with XbaI
and PacI before being ligated to two DNA fragments (PacI/MluI
and MluI/XbaI) derived from p59VEErep/L/GFP/Pac v.2,
resulting in the NS2-expressing VEE replicon constructs. The
NS2-S168A and S168G mutations were introduced subsequently
by QuikChange mutagenesis. To introduce the NS2-L174V
mutation, HJ3-5 was digested with BglII/MluI and ligated to a
PCR fragment containing both NS2-S168G and L174V muta-
tions. C-terminal NS2 deletion mutants DC63, DC119, DC147
were constructed using QuikChange mutagenesis. The integrity of
the constructs was validated by DNA sequencing of the
manipulated regions.
Cells
FT3-7 and Huh-7.5 cells are clonal derivatives of Huh7 human
hepatoma cells [14,33]. They were grown in DMEM containing
10% FBS and 16penicillin/streptomycin at 37uC in a 5% CO2
environment. VEE replicon cells were cultured in the same
medium plus 1 mg/ml puromycin (Invitrogen).
HCV RNA transfection and virus production
HCV RNAs were transcribed in vitro and electroporated into
cells as described previously [34]. In brief, for electropora-
tion,10 mg of in vitro-synthesized HCV RNA was mixed with
5610
6 FT3-7 cells in a 2-mm cuvette and pulsed twice at 1.4 kV
and 25 mF in a Gene Pulser II (BioRad) apparatus. Cells were
subsequently seeded into 12-well plates for analysis of HCV RNA.
For virus production, transfected cells were seeded into 25-cm
2
flasks and fed with medium containing 10% FBS. Cells were split
every 3–4 days.
Quantitation of HCV RNA
Total RNA was isolated from cell lysates using an RNeasy kit
(Qiagen) in accordance with the manufacturer’s instructions. RNA
wasisolatedfromcellculturesupernatantsandgradientfractions(see
below) using a QIAamp viral RNA kit (Qiagen). For monitoring
RNA replication in transfected cells, we assayed viral RNA
abundance in a quantitative real-time RT-PCR reaction carried
out in a Bio-Rad iQ5 Real-time PCR Detection System using Taq-
Man chemistry and the forward primer HCV84FP (59-GCCAT-
fo]GGCGTTAGTATGAGTGT-39), reverse primer, HC300R (59-
CCCTATCAGGCAGTACCACAA-39), and detection probe:
FAM (6-carboxy-fluorescene)-TCTGCGGAACCGGfo]TGAG-
TACACC-DBH (dual-labeled probe Black Hole Quencher)-1.
HCV infectivity assays
For virus titration, 100-ml aliquots of serial 10-fold dilutions of
supernatant cell culture fluids (clarified by low-speed centrifuga-
tion), clarified freeze-thaw cell lysates, or iodixanol or sucrose
gradient fractions (see below), were inoculated onto naı ¨ve Huh-7.5
cells seeded 24 h previously into 8-well chamber slides (Nalge
Nunc) at 3610
4 cells/well. Cells were maintained at 37uCi na5 %
CO2 environment and fed with 200 ml of medium 24 h later.
Following 48 h additional incubation, cells were fixed in 1:1
methanol-acetone at room temperature for 9 min, then stained
with monoclonal antibody C7-50 to core protein (Affinity
BioReagents, 1:300) for 2 h at 37uC, washed with PBS twice,
and incubated with fluorescein isothiocyanate-conjugated goat
anti-mouse immunoglobulin G (Southern Biotech, 1:100) for
Figure 10. A model for sequential involvement of non-structural proteins in HCV assembly, maturation, and egress. Particle assembly
follows the recruitment of core, followed by NS5A and NS3 to the surface of lipid droplets. Such particles are noninfectious, however, and must
undergo a maturation step mediated by NS2 (most likely in concert with NS5A) prior to becoming infectious and exiting the cell. See the Discussion
for details.
doi:10.1371/journal.ppat.1000403.g010
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were considered to constitute a single infectious focus-forming unit
(FFU), as described previously [4,7,14]. Infectivity titers (FFU/ml)
were calculated from the results obtained with sample dilutions
yielding 5 to 100 FFU.
Immunoblotting of viral proteins
Immunoblots of cell lysates were probed with antibody to core
(C7-50, Affinity BioReagents; 1:30,000 dilution), anti-Flag M2
(Sigma, F3165; 1:1000 dilution), anti-Myc (Sigma, M5546; 1:1000
dilution) followed by horseradish peroxidase-conjugated anti-
mouse IgG (Southern Biotech, no. 1030-05; 1:30,000). Proteins
were visualized by chemiluminescence using reagents provided
with the ECL Advance kit (Amersham Biosciences).
In vitro translation
For in vitro translation of HCV polyprotein segments expressing
NS2-NS3-NS4A derived from HJ3 with or without the NS2-
S168A mutation, 1 mg of in vitro transcribed RNA was used to
program in vitro translation reactions in rabbit reticulocyte lysate
(Promega) in a 50 ml reaction mixture containing 2 mlo f[
35S]-
methionine (1,000 Ci/mmol at 10 mCi/ml), 2.5 ml of canine
pancreatic microsomal membranes and 1 ml of an amino acid
mixture lacking methionine at 30uC for the indicated time.
Reactions were stopped by the addition of SDS sample buffer and
boiling for 10 min. Translation products were separated by SDS-
PAGE followed by autoradiography.
Laser-scanning confocal microscopy
Transfected cells were seeded onto 8-well chamber slides and 2–
3 days later washed three times with PBS, fixed with 4%
paraformaldehyde, and permeabilized with 0.1% Triton X-100
for 10 min [27]. Cells were labeled with monoclonal antibody C7-
50 to core protein (Affinity BioReagents, 1:400) and rabbit
polyclonal antibody to NS5A (a generous gift of Dr. Craig
Cameron, 1:300 dilution) followed by goat anti-mouse immuno-
globulin G conjugated to Alexa-488 and goat anti-rabbit
immunoglobulin G conjugated to Alexa-594 (Invitrogen, 1:200).
Neutral lipids present in lipid droplets were visualized by staining
with LipidTOX Deep Red (Invitrogen). Nuclei were visualized by
counterstaining with DAPI (1:1000). To detect NS2 protein
containing Myc- or Flag-tag sequences, cells were incubated
monoclonal anti-Myc antibody (Sigma, M5546; 1:100 dilution) or
Rabbit anti-Flag antibody (Sigma, F7425; 1:100 dilution). E2
protein was detected using the human monoclonal antibody CBH-
7 (kindly provided by Steven Foung, Stanford University) at a
1:100 dilution. Slides were examined with a Zeiss LSM 510 Meta
laser-scanning confocal microscope.
Rate-zonal centrifugation of HCV particles
Cell lysates were prepared for intracellular virus infectivity
assays as described by Gastaminza et al. [35]. Briefly, cell pellets
harvested after trypsinization were resuspended in complete
media, washed twice with PBS, lysed by four cycles of freezing
and thawing, and clarified by centrifugation at 4000 rpm for
5 mins. A 250 ml volume of lysate was loaded on a preformed
continuous 10 to 50% sucrose gradient prepared in TNE (10 mM
Tris, pH 8.0, 150 mM NaCl, 2 mM EDTA) and centrifuged for
1 h at 40,000 rpm (,200,0006g) in a SW41 Ti rotor at 4uC. A
total of 40 fractions (300 ml each) were collected from the top of
the gradient and subjected to immunoblot analysis, to determine
the distribution of core protein, and virus titration to determine
the location of infectious virus within the gradient. The density of
gradient fractions was estimated from the refractive index
determined with a Milton-Roy refractometer.
Isopycnic gradient centrifugation of HCV particles
Three days following electroporation of cells with HCV RNA,
clarified cell lysates (prepared after multiple freeze-thaw cycles as
described above) were layered on top of 10 to 40% iodixanol
gradients prepared in Hanks balanced salt solution. Gradients
were centrifuged in an SW60 rotor (Beckman Coulter) at
45,000 rpm for 16 h at 4uC, and nine fractions (500 ml each)
were collected from the top of the tube. The density of gradient
fractions was estimated from the refractive index determined with
a Milton-Roy refractometer.
Quantitative core protein ELISA
Core protein was quantified in gradient fractions using the Ortho
Trak-C ELISA kit (Ortho-Clinical Diagnostics) with minor modi-
fications to the manufacturer’s recommended procedures. Cell
culture supernatant or lysates derived from FT3-7 cells transfected
with HJ3-5 with or without the NS2-S168G mutation were pre-
diluted 10- to 200-fold in the dilution buffer supplied with the kit (so
that OD490 values were within range of the standard solutions) prior
to incubation in the ELISA plates at room temperature for 1 h. The
quantity of core protein present in fractions was estimated from the
OD490 by reference to a standard curve.
CK2 inhibitor treatment
Cells were treated with the CK2 inhibitor, 2-dimethylamino-
4,5,6,7-tetrabromo-1H-benzimidazole (DMAT, EMD Bioscienc-
es), as described by Tellinghuisen et al [8]. FT3-7 cells were
treated with a range of concentrations (0.1, 1, 10 mM) of DMAT
beginning 4 h after electroporation with HCV RNA, with
treatment continued until 24 h post-electroporation. We measured
the titer of infectious virus present in the cell culture supernatant at
48 h post-transfection.
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